Public Alert No. 05/2024 – Sales of Unregistered Seretide Accuhaler on Instagram and Online Media
The National Agency for Food and Drug Administration and Control (NAFDAC) is notifying the public of the sales of unregistered Seretide Accuhaler on Instagram and online media. On investigation, a team of NAFDAC officials visited the two addresses and got the unregistered Seretide Accuhaler in one of the locations specifically 14 Lanre Hassan Street by […]
Public Alert No. 04/2024 –Alert on recall of Brexafemme® tablets 150 mg due to risk of cross-contamination
The National Agency for Food and Drugs Administration and Control (NAFDAC) is informing the public that Scynexis, Inc is conducting a voluntary nationwide recall of two (2) lots of BREXAFEMME® (ibrexafungerp tablets) 150 mg to the consumer level in the US market as reported by the United States (US) Food and Drug Administration (FDA). This recall is due […]
Public Alert No. 03/2024 – Alert on Sale of Counterfeit Arla Dano Full Cream Milk Powder- 14g Sachet Across Nigerian Market
The National Agency for Food and Drug Administration and Control (NAFDAC) is notifying the public of the sale of counterfeit Arla Dano 14g full cream Milk Powder across states in Nigeria. Investigations by the TG Arla Dairy Product Enterprise company (Holder of Certificate of Registration) discovered that the counterfeited products were displayed openly in the market. The details of […]
Public Alert No. 02/2024 –Pfizer warns against Tampered Expiry date on Prevenar 13 batch CL 3337
The National Agency for Food and Drugs Administration and Control (NAFDAC) is notifying healthcare providers that Pfizer has warned on the presence of boxes of probable authentic Prevenar 13 displaying tampered expiry date. According to the Marketing Authorization Holder (MAH) Pfizer, a patient notification received from Nigeria informed the company of a suspicious pack of […]
Public Alert No. 01/2024 –Alert on falsely labelled OZEMPIC (Semaglutide, 1 mg, solution for injection) Pens
The National Agency for Food and Drugs Administration and Control (NAFDAC) is informing the public about the circulation of pre-filled pens falsely labeled as the diabetes medicine, Ozempic (semaglutide, 1 mg, solution for injection) which was identified at wholesalers in the European Union and the UK as reported by the European Medicines Agency (EMA). The […]
